IDEAYA Biosciences (IDYA) FCF Margin (2020 - 2026)
IDEAYA Biosciences (IDYA) recorded FCF Margin of -1005.72% in Q2 2026, up 154.90 percentage points from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) FCF Margin (2020 - 2026) Analysis & Trends
On a TTM basis, IDEAYA Biosciences' FCF Margin came in at -48.64% as of Jun 30, 2026; for FY2025, it was -33.59%, up 3558.42 percentage points from FY2024.
- Annual FCF Margin has a five-year change of -314.94 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at -3592.01% in FY2024 (-3089.16 pp), -502.85% in FY2023 (-324.93 pp), -177.92% in FY2022 (+31.17 pp) and -209.09% in FY2021 (-490.44 pp).
- Quarterly FCF Margin has ranged from -1753.67% in Q4 2024 to 68.41% in Q3 2025 over the past five years.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 918.54 percentage points in Q4 2025, against a drop of 1147.30 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -1160.63% (Q1 2026), -835.13% (Q4 2025) and 68.41% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.89 Bn | 1,138.48 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 648.35 Bn | 568.21 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 504.24 Bn | 477.35 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 365.96 Bn | 320.33 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 303.28 Bn | 267.27 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 242.76 Bn | 198.16 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 194.96 Bn | 169.16 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 172.99 Bn | 119.64 Bn | 10.94 Bn | 2.01% |
| 10 | IDEAYA Biosciences | 3.30 Bn | 369.36 Mn | - | -1,005.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,005.72% |
| Mar 31, 2026 | -1,160.63% |
| Dec 31, 2025 | -835.13% |
| Sep 30, 2025 | 68.41% |
| Dec 31, 2024 | -1,753.67% |
| Dec 31, 2023 | -626.87% |
| Sep 30, 2023 | -382.89% |
| Jun 30, 2023 | -969.07% |
| Mar 31, 2023 | -353.87% |
| Dec 31, 2022 | -581.05% |
| Sep 30, 2022 | -85.08% |
| Jun 30, 2022 | -374.86% |
| Mar 31, 2022 | -176.49% |
| Dec 31, 2021 | -582.78% |
| Sep 30, 2021 | -144.01% |
| Jun 30, 2021 | -154.27% |
| Mar 31, 2021 | -203.22% |
| Dec 31, 2020 | -111.39% |
| Sep 30, 2020 | 1,003.29% |
API Access
IDEAYA Biosciences FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();